In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure:
and at least one guanidinium residue, wherein m is zero or a positive integer. Also disclosed are methods of preparing the disclosed compounds. Also disclosed are methods of intracellular delivery comprising administering the disclosed compounds and compositions to a subject. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of one or more compounds or compositions of the invention and a pharmaceutically acceptable carrier. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
根据本发明的目的,本发明在一个方面涉及包含以下结构的化合物,以及至少一个
鸟氨酸残基,其中m为零或正整数。还公开了制备所述化合物的方法。还公开了包括将所述化合物和组合物给予受试者的细胞内递送方法。还公开了包括本发明的一个或多个化合物或组合物的治疗有效量和药学可接受载体的制药组合物。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。